Maria Clotilde Carra1,2,3, Alice Gueguen3, Frédérique Thomas4, Bruno Pannier4,5,6, Giuseppina Caligiuri7, Philippe Gabriel Steg7,8,9,10, Marie Zins3, Philippe Bouchard1,2,11. 1. Department of Periodontology, Service of Odontology, Rothschild Hospital, AP-HP, Paris, France. 2. U.F.R. of Odontology, Paris 7-Denis Diderot University, Paris, France. 3. Population-based Epidemiologic Cohorts Unit, Inserm, UMS 011, Villejuif, France. 4. Centre d'Investigations Préventives et Cliniques (IPC), Paris, France. 5. Department of Cardiology, Georges Pompidou European Hospital, AP-HP, Paris, France. 6. Medicine Faculty, Paris 5-Descartes University, Paris, France. 7. INSERM-Unité 1148, Paris, France. 8. French Alliance for Cardiovascular Trials (FACT), Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France. 9. Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France. 10. Royal Brompton Hospital, Imperial College, London, UK. 11. EA 2496, Paris 5-Descartes University, Paris, France.
Abstract
AIM: To derive from a validated questionnaire a periodontal screening score (PESS), intended as a user-friendly tool to identify individuals at risk of periodontitis in epidemiological studies. METHODS: A French 12-item self-reported questionnaire was developed by translating English questions previously used for periodontitis screening and surveillance. After a cognitive evaluation, the questionnaire was validated in a sample of 232 individuals (mean age: 46.1 ± 12.6 years) receiving full-mouth periodontal examination, including probing pocket depth and clinical attachment level recordings. Case definition was based on the American Academy of Periodontology/Centers for Disease Control and Prevention criteria. Logistic regression analyses and C-statistics were used to assess the validity and accuracy of the questionnaire and to develop the PESS. RESULTS: The sample was constituted of 109 individuals with severe periodontitis, who were compared with 123 individuals with no/moderate periodontitis. The questionnaire had moderate-to-high accuracy in identifying severe cases; the PESS (calculated on five self-report items, age, and smoking) showed a sensitivity of 78.9% and a specificity of 74.8%, with an area under the receiver operating characteristics curve of 0.821. CONCLUSION: The PESS represents a valuable and accurate tool to screen for severe periodontitis at the population level.
AIM: To derive from a validated questionnaire a periodontal screening score (PESS), intended as a user-friendly tool to identify individuals at risk of periodontitis in epidemiological studies. METHODS: A French 12-item self-reported questionnaire was developed by translating English questions previously used for periodontitis screening and surveillance. After a cognitive evaluation, the questionnaire was validated in a sample of 232 individuals (mean age: 46.1 ± 12.6 years) receiving full-mouth periodontal examination, including probing pocket depth and clinical attachment level recordings. Case definition was based on the American Academy of Periodontology/Centers for Disease Control and Prevention criteria. Logistic regression analyses and C-statistics were used to assess the validity and accuracy of the questionnaire and to develop the PESS. RESULTS: The sample was constituted of 109 individuals with severe periodontitis, who were compared with 123 individuals with no/moderate periodontitis. The questionnaire had moderate-to-high accuracy in identifying severe cases; the PESS (calculated on five self-report items, age, and smoking) showed a sensitivity of 78.9% and a specificity of 74.8%, with an area under the receiver operating characteristics curve of 0.821. CONCLUSION: The PESS represents a valuable and accurate tool to screen for severe periodontitis at the population level.
Authors: Mohamed Attauabi; Gorm Roager Madsen; Flemming Bendtsen; Anne Vibeke Wewer; Rune Wilkens; Johan Ilvemark; Nora Vladimirova; Annette Bøjer Jensen; Frank Krieger Jensen; Sanja Bay Hansen; Hartwig Roman Siebner; Yousef Jesper Wirenfeldt Nielsen; Jakob M Møller; Henrik S Thomsen; Simon Francis Thomsen; Helene Andrea Sinclair Ingels; Klaus Theede; Trine Boysen; Jacob T Bjerrum; Christian Jakobsen; Maria Dorn-Rasmussen; Sabine Jansson; Yiqiu Yao; Ewa Anna Burian; Frederik Trier Møller; Viktoria Fana; Charlotte Wiell; Lene Terslev; Mikkel Østergaard; Kristina Bertl; Andreas Stavropoulos; Jakob B Seidelin; Johan Burisch Journal: BMJ Open Date: 2022-06-27 Impact factor: 3.006
Authors: Lauranne Jaumet; Zeineb Hamdi; Chantal Julia; Serge Hercberg; Mathilde Touvier; Philippe Bouchard; Maria Clotilde Carra; Valentina A Andreeva Journal: Qual Life Res Date: 2022-08-10 Impact factor: 3.440
Authors: Thomas Veynachter; Valérie Orti; Estelle Moulis; Hélène Rousseau; Nathalie Thilly; Fani Anagnostou; Sylvie Jeanne; Catherine Bisson Journal: Int J Environ Res Public Health Date: 2020-11-18 Impact factor: 3.390
Authors: Iulia C Micu; Sorana D Bolboacă; Gabriela V Caracostea; Diana Gligor; Andreea Ciurea; Sofia Iozon; Andrada Soancă; Daniel Mureșan; Alexandra Roman Journal: PLoS One Date: 2020-08-18 Impact factor: 3.240